LUNCH SATELLITE SESSION- NOVO NORDISK

12:30-14:30   Wednesday, 26 April, 2017

Lunch Session- Novo Nordisk-Hall J

A New Horizon in the Treatment of the Cardio Metabolic Patient

Faculty: Hila Knobler, Naim Shechade

 
 Time TopicSpeaker
12:30-13:00Lunch first and main courses 
13:00-13:30Beyond Glucose Control -
Liraglutide treatment in diabetes leading to CV risk reduction (LEADER® trial)
 Hila Knobler 
13:30-13:55
Beyond the SCALE – Liraglutide 3 mg in the treatment of obesity (SCALE® trial) Naim Shechade
13:55-14:10
Q&A
 

 

 

To Register Click Here